We propose two computational methods for predicting if a protein produced by fusion of genes will conserve the structures of the fused proteins. We use two complementary paths for prediction. The former is a simulation from the sequence while the latter exploits its expected structure. Early stages of protein folding are simulated from their amino acid sequence by capturing the most interacting residues (MIR). Individual domain structures (or models) are superposed onto the predicted complex structure (or model). When no structure exists, a model is calculated using a set of ab initio and fold recognition tools. These results are used to predict the validity of the chimeric protein. We test the two methods against a dataset of 10 proteins.
INTRODUCTION
Protein fusion is a process that consists of the creation of a chimeric protein from parent ones, see Figure 1 . The structure of a protein is correlated to its function (Chandonia and Brenner, 2006) , so if the structure of a domain is altered when fused to a partner, the function can be impaired. The motivation is that the functions of the parent proteins are conserved in the complex and will work in tandem. This has applications in drug design, see (Peppel, Crawford, and Beutler, 1991) . The challenge is this: by fusing two proteins together, is it possible that they may fold incorrectly, thus affecting the desired function? Ideally, function is conserved.
We first use a simulation method that predicts the most interacting residues (MIR), which can delineate the folding nucleus (Papandreou, et al., 2004) . The lack of conservation of MIRs may predict structural differences. The MIR simulation was shown to corroborate simulations such as tightened end fragments (TEF) and the calculation of free energy change upon mutation (Lonquety, Lacroix, Papandreou and Chomilie, 2009; Lonquety, Chomilier, Papandreou and Lacroix, 2010) . We also compare our sequence predictions with structural conservation of the complex relative to the component domains. 
RELATED WORK
The MIR algorithm (Papandreou, et al., 2004 ) is designed to calculate the number of residues a given residue interacts with early in the folding process, capturing local structural information. A cubic lattice is constructed containing the protein. The algorithm selects a random conformation fitting the lattice. The algorithm then iterates, randomly moving residues and analyzing the energy of the new structure. MIR positions correspond to the residues with the highest number of non-covalent neighbors during the simulation.
Typically, chimeric proteins must be experimentally tested. However, structure prediction tools such as QUARK (Xu and Zhang, unpublished; Xu and Zhang, unpublished; Zhang Lab, 2011) , I-TASSER (Roy, Kucukural and Zhang, 2010; Zhang, 2009) , and Phyre2 (Kelley and Sternberg, 2009 ) can be used. As I-TASSER and Phyre2 use known proteins, they may be biased towards a chimera's structure when modeling its components. We can evaluate whether each parent domain superposes on the chimera. Protein structure superposition potentially captures protein similarities not predicted by sequence alignments. Table 1 : Each chimeric product is described by its name with its component domains (col. 1), the residue of the sequence (col. 2), and if the product folds into an oncoprotein (col. 3). The source of their sequence is then indicated (col. 4); products from KEGG are listed with their ID, from PDB with PDB ID and from NCBI with GenBank Accession. It is shown if the sequence has a structure PDB entry or model (col. 5 and 6). 
METHOD
Given a chimera and its parent domains, we calculate the MIR in their sequences and determine if fusion significantly changes the interactions in the fused domains. A large discrepancy in the distribution of the MIRs in the parent domains and the fused protein may allow us to conclude the absence of a correct fold. We also compute a model from the sequences and superpose the parent domains onto the chimera. In the simplest fusion protein, a sequence is directly appended to another sequence so as to produce a larger protein containing both sequences. This organization holds for engineered chimeras, but chimeric proteins also form naturally (e.g. translocation). In Figure 1 , we showed the more general case where a spacer (or ligation scar) exists between the two fused domains. While folding, a spacer orientates and distances the two fused domains to better allow their independent folding.
Our dataset is comprised of two groups of sequences: a) products of chimeras known to fold with conservation of folding of the individual parent domains, b) chimeric products of oncogenes, thus known to fold incorrectly. Proteins were selected using the following criteria: 1) The atomic coordinates must be determined for all residues. 2) Relatively short. 3) Minimal spacer. We assume that the sequence is cDNA. See Table 1 . We retrofit the chimeric protein sequence by splitting it into its parent sequences using BLAST. We assume that each chimeric protein is the result of appending precisely two parent domains. In order for the whole chimeric protein to fold correctly, it would be required that any spacer did not interfere with the attached protein. Consider the component protein and spacer as a whole to be a protein; we then have two components to fuse which fits our methodology.
The primary structures of the target proteins were used to produce MIR predictions. For our computations, we used an implmentation called MIR 2.2beta (Papandreou, et al., 2004) . QUARK was selected as our ab initio modeler based on its performance in CASP9 (Protein Structure Prediction Center, 2010), while I-TASSER was selected for its association with QUARK. Phyre2 was selected for its accuracy among fold recognition tools. We expect that the percentage of the components which superpose with the chimeric proteins would be much greater in the chimeric proteins which are known to fold correctly. Superposition was performed with GANGSTA+.
RESULTS
For the MIR prediction, we first used a threshold of seven interactions (Papandreou, et al., 2004) to locate MIR. We list the positions along the sequence where a MIR differs when comparing the computations for an individual component to the entire fused protein. Figures 2 and 3 show these results for two extreme cases, the most divergent and the most alike. The results of the structural alignments are shown in Tables 2 and 3 . We define maximum alignment to be the length of the component sequence divided by the length of the chimeric sequence. The superposition column indicates the portion of the component model that can be superposed onto the chimera. For each alignment, we also give the RMSD produced by GANGSTA+ (Guerler and Knapp, 2008) . In three cases, GANGSTA+ could not calculate a result due to a lack of secondary structure. In another, a model could not be computed to use with GANGSTA+, because CBL is peptide rather than a protein. When more than one model was produced, we picked the model with the highest reported confidence (Xu and Zhang, unpublished; Roy, Kucukural and Zhang, 2010) . 
DISCUSSION
An analysis of the MIR data would ideally show similar MIRs. A change in MIRs might indicate a disruption during folding. In general, the MIR results are noisy due to the Monte Carlo algorithm. In several cases, we see a peak in interactions at the point of fusion due to lengthening of the sequence. In the PHD3/Cyp33 fusion, the changes are few enough (3 in 140 residues) to be accounted for by the algorithm. This indicates that the protein should fold correctly, as it is known from experiment. GST/EGFP (figure 2), also known to have a conserved function after fusion, has nevertheless differences in MIRs. In the BRD4/NUT fusion (figure 3), we see a plateau where 19 residues change their MIR status. We suspect it may be a motif indicating failure to fold. The remaining proteins do not give conclusive results. The superposition analysis is shown in Tables 4  and 5 . The RMSD column is computed with GANGSTA+. Our expectation is that the majority of the models of proteins known to fold correctly can be better superposed while the models from the oncoproteins have minimal superposed results. The mean RSMD in the set of conserved fold proteins is 2.36 Å, while it is 2.83 Å in the set of oncoproteins.
Of the known correct proteins, 4 have good superposition, with a superposition including at least 75% of residues and a RMSD less than 2 Å. The remaining models give superpose results of 14.77% to 79.56%. Interestingly, only 14.77% of the TRIM5 component was superposed. This is likely due to the inaccuracy inherent in structural prediction. Of the oncoproteins, 4 of the models have superpositions including less than 12% of residues. In particular, GANGSTA+ cannot find any way to superpose the anaplastic lymphoma kinase onto the model of its chimera. The remaining models range from 72.08% to 81.11% match. We found only one sequence where the results of the methods corroborate. In the case of the Cyp33 component of the PHD3/Cyp33 fusion (which is known to fold correct), the MIR results indicated almost no change. Likewise, the superposition tool superposed 98.72% of the residues in the component.
FUTURE WORK
Improvements on the MIR algorithm are being made by Nikolaos Papandreou. The new implementation calculates SMIRs (smoothed MIR) which are more stable across separate computations. By using QUARK to predict all unknown structures, we would reduce any variance that is introduced by the use of multiple tools. This would also remove any prediction tool bias from an analogous existing structure. During the analysis of the proteins listed in Table 1 , we assumed all chimeric proteins were the result of directly appending one protein to another.
Our dataset should be expanded with additional chimeric proteins containing more than two components.
CONCLUSIONS
In this paper we have presented methods for predicting the potential of chimeric proteins to fold correctly. A set of proteins was analyzed using first a MIR tool and then a superposition tool. The results of the MIR method were inconclusive. In many cases similar patterns were seen in the correctly folded proteins as well as the oncoproteins. In the case of superposition, the correctly folded proteins superposed significantly while many of the oncogenes superposed minimally. In comparing the results of the two methods, we found only one instance where they agreed. Based on our results, the application of superposition tools is capable of providing some insight into the potential folding of chimeric proteins. 
